Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chunghwa Medipower is a South Korean medical device and biotechnology company specializing in the development and manufacture of advanced soft tissue fillers. Founded in 2007, the company is best known for its proprietary technology combining cross-linked dextran and PMMA microspheres to provide long-lasting aesthetic and functional results. Its product portfolio includes LiCOL for facial wrinkle correction, Lipen for penile augmentation, Winkfeel for vaginal laxity, and Dexsol for pediatric vesicoureteral reflux. Beyond its commercial filler line, Chunghwa Medipower is actively engaged in R&D focused on regenerative medicine, including stem cell-derived extracellular vesicles (EVs) and exosomes. The company operates a GMP-certified manufacturing facility in Jangseong and maintains a research presence in Seoul to support its global expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chunghwa Medipower.